XIST and hepatocellular carcinoma: Furthermore, as a result of Kaplan–Meier survival analysis, patients with higher XIST in HCC had a conspicuously better prognosis than those with lower XIST, with a higher OS (p = .0015) (Figure 4C) and more extended recurrence‐free survival (RFS) (p = .0006) (Figure 4D).